— Achieved key clinical and regulatory milestones across clinical pipeline, including the completion of enrollment in Longeveron’s Phase 2a trial for Alzheimer’s Disease — — Conference call scheduled for 8:30 a.m. ET today — MIAMI, Nov. 14, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical […]
Author: Ken Dropiewski
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
WALTHAM, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the quarter ended September 30, 2022, and recent business highlights. Recent Highlights Progress Continued […]
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today reported financial results for the third quarter ended September 30, 2022 and provided key business updates. “The Company had several notable deliverables this quarter […]
Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification
UPPSALA, Sweden, Nov. 14, 2022 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink® Flex, a fully flexible made-to-order product to select and combine up to 21 human proteins using absolute quantification in one biomarker panel. With the introduction of Olink® Flex, the […]
Cardio Diagnostics Holdings Inc CEO Meesha Dogan, Accepted into Forbes Technology Council
Forbes Technology Council Is an Invitation-Only Community for World-Class CIOs, CTOs, and Technology Executives. CHICAGO–(BUSINESS WIRE)–Meesha Dogan, PhD, the CEO of Cardio Diagnostics (Nasdaq: CDIO), a precision cardiovascular disease company, has been accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives. Cardio Diagnostics is a biotechnology […]
Hello Heart Adds Breakthrough Artificial Intelligence (AI) Capabilities to Empower Users to Make Better Choices
Users now have access to deeper insights and personalization to support positive choices regarding their heart health MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the only digital therapeutic that focuses exclusively on heart health, today announced Dot-to-Dot, a new addition to their digital whole heart health program. Dot-to-Dot is a breakthrough feature that […]
Preliminary Data from AAA-SHAPE to be Presented at VEITH 2022
SANTA CLARA, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral vascular and neurovascular markets, announced preliminary six-month results from the AAA-SHAPE Safety Trial. Data will be presented during the 49th Annual VEITH Symposium in New York City on Tuesday, November 15, 2022. AAA-SHAPE is […]
Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives by providing disruptive therapies for the interventional treatment of vascular disease, announced the 12-month results of the DETOUR 2 trial during a late-breaking clinical trial session at the 2022 VIVA Vascular InterVentional Advances (VIVA) […]
CHOCOLATE TOUCH®, NEXT-GENERATION DRUG-COATED ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE RECEIVES FDA APPROVAL
SINGAPORE, Nov. 11, 2022 /PRNewswire/ — Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed by TriReme Medical LLC, for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery. The Chocolate […]
ISHLT Expands Research Funding for Advanced Heart and Lung Disease: Applications Open Now
CHICAGO, Nov. 11, 2022 /PRNewswire/ –The International Society for Heart and Lung Transplantation (ISHLT) is now accepting applications for four research grants to be awarded during the first 2023 grant cycle, which concludes with the announcement of winners at the ISHLT Annual Meeting in Denver in April 2023. Applications for these grants will be accepted […]
